Hepatitis Monthly. 2004; 4 (7): 71-74
en Inglés
| IMEMR
| ID: emr-203599
ABSTRACT
Background and aims:
peginterferon alpha-2a is a known standard therapy for patients with chronic HCV infection. However, efficacy and safety of this treatment is still unclear in regional settings. This study was designed to clarify efficacy and safety of peg-interferon based therapy in Iranian patients
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Hepat. Monthly
Año:
2004
Similares
MEDLINE
...
LILACS
LIS